Why Bulletproof Medical Chronologies Win Bankruptcy Trust Payouts

A tort claim argues. A trust claim proves. Most record files are built for the first job.

Your client's mesothelioma case was worth a jury verdict. Then the defendant filed Chapter 11, the litigation stayed, and eighteen months later the case came back as a claim form with a checklist attached.

That is the moment a medical chronology stops being a persuasion document and starts being an eligibility document. A claims examiner at a bankruptcy trust is not reading your theory of the case. They are checking whether the file contains a diagnosis that meets a defined standard, a latency period that clears a stated minimum, exposure dates that fall inside a fixed window, and severity findings that place the claim on the right disease level.

If any one of those is missing, the claim does not lose. It goes into deficiency, which is worse, because the clock keeps running and your paralegal now owns a records chase that could have been closed two years earlier.

Mass tort plaintiff firms are running into this more often. Corporate defendants with large legacy liabilities keep testing Chapter 11 as a resolution channel, and the restructuring bar has built practice groups around it. The tort skills that win at trial do not transfer cleanly to a trust filing. The documentation skills do.

A bankruptcy trust does not weigh your argument. It matches your file to a grid.

A bankruptcy trust pays claims according to a written rulebook called the Trust Distribution Procedures, usually shortened to TDP. The TDP is filed with the plan of reorganization and approved by the court, and it sets out every disease level the trust recognizes, the medical evidence required for each level, the exposure evidence required for each level, the scheduled dollar value assigned to each level, and the review track a claim can take.

For asbestos liabilities, this structure comes from section 524(g) of the Bankruptcy Code, which lets a reorganized company channel current and future asbestos personal injury claims into a trust and out of the tort system. Trusts formed for other mass torts borrow the same architecture, because it is the only mechanism that has been tested at scale.

Most TDPs recognize eight disease levels. The Owens-Illinois Asbestos Personal Injury Trust, to take one published example, runs from Level I (other asbestos disease) through Level IV (severe asbestosis), Level V (other cancer), Level VII (lung cancer) and Level VIII (mesothelioma). Each level carries its own medical and exposure test. Level VIII asks for a mesothelioma diagnosis by physical examination or by a board-certified pathologist, plus a 10-year latency period, plus credible evidence of exposure before December 31, 1958. Level III asks for a bilateral non-malignant finding, pulmonary function testing showing reduced capacity, a physician statement connecting the disease to asbestos, six months of debtor exposure before the same cutoff date, and five years of significant occupational exposure.

Read that again as a documentation problem rather than a legal one. Six of those elements live in the medical records. Two live in employment and social history. None of them is satisfied by a narrative that says the client worked around asbestos for years and later got sick.

Expedited review and individual review ask for different files

Trusts generally offer two tracks, and the track you choose changes what the file has to carry.

• Expedited review. The claim is matched against the published criteria for a disease level and paid the scheduled value for that level. It is faster because nobody is exercising judgment. It is also unforgiving, because a claim that misses one stated element does not get a discussion, it gets a deficiency notice.
• Individual review. The claim is evaluated on its own facts and assigned a liquidated value that can land above or below the scheduled value. Firms use this track for lung cancer claims with smoking histories, secondary or household exposure, and claims that fall outside the published criteria. Individual review rewards a fuller record and punishes a thin one, because the reviewer is weighing what you put in front of them.

Then there is the payment percentage. A trust does not pay the full scheduled or liquidated value. It multiplies that value by a payment percentage set to preserve assets for future claimants, and published 2026 comparisons of active asbestos trusts show that percentage ranging from under one percent at some trusts to one hundred percent at others. Your client's recovery is the value the file supports, multiplied by a number you cannot negotiate. The only variable in your control is the first one.

Source Credit: Disease level criteria summarized from the published Trust Distribution Procedures of the Owens-Illinois Asbestos Personal Injury Trust and the Armstrong World Industries Asbestos Personal Injury Settlement Trust. Payment percentage ranges from published 2026 trust comparisons. Confirm current criteria and percentages on each trust's own site before filing.

What the Chapter 11 shift is doing to mass tort dockets

The bankruptcy route is contested, which is exactly why plaintiff firms should assume they will meet it in both forms: as a trust that already exists, and as a filing that gets challenged.

In June 2024, the Supreme Court held in Harrington v. Purdue Pharma L.P. that the Bankruptcy Code does not authorize a plan to discharge claims against a non-debtor without the claimant's consent. That decision closed the broadest version of the third-party release and pushed restructuring practitioners toward consent-based structures, mandatory class settlements and conventional plan mechanics.

In March 2025, a Texas bankruptcy court dismissed Red River Talc LLC, the third bankruptcy vehicle Johnson and Johnson had used to try to resolve talc liability, and the company returned to the tort system. Federal talc litigation kept growing after that. The MDL centralized in New Jersey (In re: Johnson and Johnson Talcum Powder Products Liability Litigation, MDL 2738) reported more than 68,000 pending actions in mid-2026.

Two things follow for a plaintiff firm. First, an inventory can move between the tort track and a trust track with very little warning, so the record file has to be built to satisfy the stricter of the two from the start. Second, the trusts that already exist, dozens of them across asbestos and other legacy exposures, are paying claims right now under criteria that have not softened.

Source Credit: Harrington v. Purdue Pharma L.P. (U.S. Supreme Court, June 2024). Red River Talc LLC dismissal reported March 2025 in the U.S. Bankruptcy Court for the Southern District of Texas. MDL 2738 pending case counts from published JPML docket reporting, July 2026.

The four elements a trust claim actually turns on

Strip away the differences between trusts and the same four documentation elements decide almost every claim.

1. Diagnosis, stated by the right person, in the right document

A trust wants a diagnosis it can point to, not one it has to infer. That usually means a pathology report, a physician's signed diagnostic statement, or a physical examination note from the diagnosing physician. A discharge summary that references a condition in passing, an oncology visit note that carries a diagnosis forward from an outside record, or a death certificate alone will not always clear the bar. For malignancy claims, the pathology report and the physician statement are the two documents most often requested a second time.

2. Latency, measured from a date the file can prove

Nearly every disease level carries a latency requirement, commonly 10 years between first exposure and diagnosis. That is arithmetic, and arithmetic needs two dates. The diagnosis date is usually in the records. The first exposure date is usually not, which is why it is the element most likely to be missing when the file is assembled from medical records alone.

3. Exposure, with dates, sites and duration

Exposure criteria are written as date-bounded and duration-bounded tests. One trust asks for exposure before December 31, 1958. Another asks for exposure before December 31, 1982. Several ask for six months of exposure to the specific debtor's product plus five years of cumulative occupational exposure, or five years of significant occupational exposure, which is defined in the TDP rather than left to argument. Job titles alone do not answer this. Employer names, work sites, start and end dates, trade, and the products handled do.

4. Severity, in the measured values the criteria name

Higher disease levels pay more and ask for more. Level III at the Armstrong World trust names pulmonary function values: total lung capacity below 80 percent, or forced vital capacity below 80 percent with an FEV1 to FVC ratio at or above 65 percent. Level IV names an ILO score of 2/1 or greater from a B-read of the chest film, plus total lung capacity or forced vital capacity below 65 percent. Those numbers exist inside pulmonary function test printouts and radiology reports. A chronology that summarizes them as reduced lung function has removed the only thing the examiner needed.

Where plaintiff record files break down at the trust stage

These are the failure patterns that turn a legitimate claim into a deficiency letter.

• The diagnosis is present but the source document is not. The chronology cites the condition and the underlying pathology report was never retrieved.
• Imaging reports are in the file but the bilateral finding language the criteria require was never isolated, so nobody knows whether the claim clears Level I.
• Pulmonary function testing exists as a raw multi-page printout with no extracted TLC, FVC and FEV1 to FVC values.
• The ILO B-read was never obtained, or was obtained years ago and cannot be located in the inventory.
• Employment history captures employers but not work sites, product lines or exposure start dates, so the earliest exposure date cannot be fixed.
• The client filed against several trusts with different cutoff dates, and the exposure narrative was written once, for one of them.
• Supplemental records arrived by email across four months and were never merged into the master file, so two versions of the chronology exist.
• Duplicates inflate the page count and hide a missing treatment year that only surfaces when the trust asks for it.

None of these are exotic. They are what happens when a 4,000 page record set is organized for a deposition and then repurposed for a claim form.

What a trust-ready medical chronology looks like

A trust-ready chronology is built backward from the TDP. Here is the structure that survives review.

• Criteria-mapped index. Each element the trust requires gets a line, and each line points to the exact document, page and date that satisfies it. The examiner should never have to search.
• A dedicated diagnosis section. Diagnosis, diagnosing physician, credentials, date, and the source document type, separated from the treatment timeline.
• An exposure timeline held apart from the medical timeline. Employer, site, job title, trade, products handled, and start and end dates, drawn from employment records, social history entries, prior sworn statements and intake forms, with each entry sourced.
• Extracted objective values. PFT values, ILO scores, and pathology findings pulled out of the source documents and shown as values with dates, with the page reference beside them.
• An explicit latency calculation. First documented exposure date, diagnosis date, elapsed years, and the document each date came from.
• A missing records log. What was requested, from whom, on what date, and what came back. This is the difference between a gap you can close and a gap you discover during review.
• A flagged inconsistency list. Conflicting onset dates, a smoking history recorded three different ways, an employer that appears in the intake form but not in the medical social history. Flagged, dated and sourced, so counsel can address it before the trust does.

Notice what this list does not include. It does not include an opinion on whether exposure caused the disease, whether the client qualifies for a disease level, or what the claim is worth. Those determinations belong to the treating and retained physicians, to counsel, and to the trust. The chronology organizes the documented evidence and flags what is missing. That is the whole job, and it is the part that decides the outcome.

How high-volume firms handle multi-trust filings

Firms that file across several trusts stop treating each claim as a separate research project and build one master evidence file per client, then map it to each trust's criteria.

One organized record set. One exposure timeline covering every employer and site. One extracted set of objective values. Then a mapping layer per trust, because the cutoff dates and duration thresholds differ. This is why a chronology that has already isolated exposure dates and severity values scales across five filings, and a narrative summary does not.

Questions to ask before you file

• Which TDP version is currently in effect, and when was it last amended?
• Does the claim clear the latency requirement using dates we can document, not dates the client recalls?
• Is the diagnosis supported by the document type the criteria name, and do we have that document in hand?
• Do we have the exposure start date, or only the employer?
• Have the pulmonary function values and any ILO score been extracted and verified against the source reports?
• Which trusts share overlapping exposure periods for this client, and does one exposure timeline satisfy all of them?
• What is outstanding on the records request log, and how long has it been outstanding?
• If this claim goes to individual review instead of expedited review, is the file strong enough to support a higher liquidated value?

The Bottom Line

A mass tort case that moves into a bankruptcy trust stops rewarding advocacy and starts rewarding documentation. The trust will not ask what happened to your client. It will ask which document proves it, on what date, and where in the file it sits.

Firms with large inventories feel this as arithmetic. A deficiency rate of even ten percent across a few thousand claims is thousands of hours of rework, spread across paralegals who were already booked, on claims that were valid the whole time. The fix is upstream, in how the record file is built, not downstream in how quickly the deficiencies get answered.

LezDo TechMed builds medical chronologies that isolate diagnosis documents, extract objective test values, hold the exposure timeline separately, and log what is missing, so counsel can see whether a claim meets a trust's criteria before it is filed. LezDo organizes and flags the documented evidence. The attorneys, the physicians and the trust make the determinations.

Source Credit: Trust criteria examples drawn from the published Trust Distribution Procedures of the Owens-Illinois Asbestos Personal Injury Trust and the Armstrong World Industries Asbestos Personal Injury Settlement Trust. Case law reference: Harrington v. Purdue Pharma L.P. (U.S. Supreme Court, June 2024). Red River Talc LLC dismissal, U.S. Bankruptcy Court for the Southern District of Texas, March 2025. MDL 2738 docket counts from published JPML reporting, July 2026. Performance metrics derived from LezDo TechMed's internal project data. This article is general information for legal professionals and is not legal or medical advice.